Skip to content

Clinical trials

COVID-19 trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: COVID-19 Country / region: Japan Clear all

73 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20161
202023
202121
202212
20236
20244
20252
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed49
Recruiting8
Terminated7
Unknown status6
No longer available1
Enrolling by invitation1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer10
AstraZeneca8
ModernaTX, Inc.6
Shionogi5
AnGes, Inc.4
Gilead Sciences4
National Institute of Allergy and Infectious Diseases (NIAID)4
Merck Sharp & Dohme LLC3
Takeda3
Genova Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
COVID-1973
Coronavirus Infections9
Virus Diseases7
Influenza, Human5
Lung Diseases4
Pneumonia4
Respiratory Tract Infections4
Severe Acute Respiratory Syndrome4
Infections3
Pneumonia, Viral3

Trials

Showing 51 to 73 of 73. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.